STAAR Surgical Company (STAA)
-NasdaqGM 8.78 
0.01(0.11%) 4:00PM EDT
| Prev Close: | 8.79 |
|---|
| Open: | 8.74 |
|---|
| Bid: | 5.89 x 600 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 9.00 |
|---|
| Beta: | 0.4 |
|---|
| Next Earnings Date: | 31-Jul-13 |
|---|
| Day's Range: | 8.50 - 8.80 |
|---|
| 52wk Range: | 4.96 - 9.45 |
|---|
| Volume: | 91,309 |
|---|
| Avg Vol (3m): | 157,898 |
|---|
| Market Cap: | 322.63M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.05 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- STAAR Surgical To Present At Upcoming Investor ConferencesPR Newswire(Tue, May 21)
- Taking a Closer Look at Medical Device and Product Companies, as Some are Generating High ROIs and Significant Free Cash Flow YieldsWall Street Transcript(Fri, May 17)
- STAAR SURGICAL CO Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Amendments to Articles ofEDGAR Online(Tue, May 14)
- STAAR SURGICAL CO FinancialsEDGAR Online Financials(Fri, May 10)
- STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Mon, May 6)
- 2 Winners and 3 Losers from This Week’s Earnings Stormat Wall St. Cheat Sheet(Sat, May 4)
- STAAR SURGICAL CO Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 3)
- Imperial Holdings, Staar Surgical: Biggest Price Gainers (IFT, STAA)at The Wall Street Journal(Thu, May 2)
- STAAR Surgical upgraded to Overweight from Equal Weight at Stephensat theflyonthewall.com(Thu, May 2)
- STAAR Surgical Company's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 1)
- STAAR Surgical Company's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 1)
- STAAR Surgical Earnings: Here’s Why the Stock is Rising Nowat Wall St. Cheat Sheet(Wed, May 1)
- Staar Surgical Co Earnings Call scheduled for 4:30 pm ET todayCCBN(Wed, May 1)
- STAAR Surgical Reports Strong First Quarter 2013 Financial ResultsPR Newswire(Wed, May 1)
- STAAR SURGICAL CO Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD DisclosureEDGAR Online(Wed, May 1)
Key Statistics
| Forward P/E (1 yr): | 30.28 |
|---|
| P/S (ttm): | 4.87 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.09 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.02 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | 3.91 |
|---|
Business Summary
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures and sells implantable lenses for the eye. It offers intraocular lenses (IOL) that include silicone Toric IOL, which is used in cataract surgery to treat preexi...
View More